According to a recent meta-analysis, TMS treatment of substance use disorders might eventually benefit patients. Dr Cochran cautions that we are not there as yet, because the researchers noted that the positive effects of rTMS appeared to be short-lived and often wore off by follow-up (on average, four months later). The results were optimistic for reducing cravings but highlighted the need to optimize how TMS is delivered for these disorders. The link for a more complete report is here, http://alert.psychnews.org/2019/07/meta-analysis-hints-at-benefits-of.html